New Approach to Establishing Market Rates May Have Major Impact on Clinical Labs

The final regulation issued recently by Centers for Medicare and Medicaid Services (CMS) addressing the process for determining reimbursement rates for clinical laboratories could potentially have a devastating impact on ” community and midsize regional independent laboratories,” according to an article on The Hill’s blog page by former Rep. J. Phillip Gingrey (R-Ga.). Read the article here…

Notice: The “Read more…” link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or socialsecurityreport.org.